• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控制脂肪细胞发育和胰岛素敏感性的主开关:过氧化物酶体增殖物激活受体γ的共价修饰

Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.

作者信息

Floyd Z Elizabeth, Stephens Jacqueline M

机构信息

Ubiquitin Biology Laboratory, Pennington Biomedical Research Resaerch Center, Louisiana Sate University Systems, Baton Rouge, LA 70808, USA.

出版信息

Biochim Biophys Acta. 2012 Jul;1822(7):1090-5. doi: 10.1016/j.bbadis.2012.03.014. Epub 2012 Apr 4.

DOI:10.1016/j.bbadis.2012.03.014
PMID:22504298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3355475/
Abstract

Adipocytes are highly specialized cells that play a central role in lipid homeostasis and the maintenance of energy balance. Obesity, an excessive accumulation of adipose tissue, is a major risk factor for the development of Type 2 diabetes mellitus (T2DM), cardiovascular disease, and hypertension. A variety of studies suggest that obesity and T2DM can be linked to a breakdown in the regulatory mechanisms that control the expression and transcriptional activity of PPARγ. PPARγ is a nuclear hormone receptor that functions as a master switch in controlling adipocyte differentiation and development. Also important in controlling glucose homeostasis and insulin sensitivity, PPARγ is a ligand-dependent transcription factor that is the functional receptor for the anti-diabetic thiazolidinediones (TZDs). In the last fifteen years, a variety of covalent modifications of PPARγ activity have been identified and studied. These covalent modifications include phosphorylation, ubiquitylation, O-GlcNAcylation and SUMOylation. Covalent modifications of PPARγ represent key regulatory mechanisms that control both PPARγ protein stability and transcriptional activity. A variety of PPARγ transgenic models, including mice heterozygous for PPARγ, have demonstrated the importance of PPARγ expression in glucose homeostasis and insulin resistance. In the following review, we have highlighted the regulation of PPARγ by covalent modifications, the interplay between these interactions and how these post-translational modifications impact metabolic disease states.

摘要

脂肪细胞是高度特化的细胞,在脂质稳态和能量平衡维持中发挥核心作用。肥胖是脂肪组织的过度蓄积,是2型糖尿病(T2DM)、心血管疾病和高血压发生的主要危险因素。多项研究表明,肥胖和T2DM可能与控制PPARγ表达和转录活性的调节机制失灵有关。PPARγ是一种核激素受体,在控制脂肪细胞分化和发育中起主控开关的作用。PPARγ在控制葡萄糖稳态和胰岛素敏感性方面也很重要,它是一种依赖配体的转录因子,是抗糖尿病噻唑烷二酮类药物(TZDs)的功能性受体。在过去十五年中,已鉴定并研究了多种对PPARγ活性的共价修饰。这些共价修饰包括磷酸化、泛素化、O-连接的N-乙酰葡糖胺化和SUMO化。PPARγ的共价修饰代表了控制PPARγ蛋白稳定性和转录活性的关键调节机制。多种PPARγ转基因模型,包括PPARγ杂合小鼠,已证明PPARγ表达在葡萄糖稳态和胰岛素抵抗中的重要性。在以下综述中,我们重点介绍了共价修饰对PPARγ的调节、这些相互作用之间的相互影响以及这些翻译后修饰如何影响代谢疾病状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a15/3355475/40358ea64241/nihms374494f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a15/3355475/d09ee2dadb19/nihms374494f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a15/3355475/40358ea64241/nihms374494f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a15/3355475/d09ee2dadb19/nihms374494f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a15/3355475/40358ea64241/nihms374494f2.jpg

相似文献

1
Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.控制脂肪细胞发育和胰岛素敏感性的主开关:过氧化物酶体增殖物激活受体γ的共价修饰
Biochim Biophys Acta. 2012 Jul;1822(7):1090-5. doi: 10.1016/j.bbadis.2012.03.014. Epub 2012 Apr 4.
2
The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes.PPARγ 翻译为过氧化物酶体增殖物激活受体γ。
Biomolecules. 2022 Dec 8;12(12):1832. doi: 10.3390/biom12121832.
3
L312, a novel PPARγ ligand with potent anti-diabetic activity by selective regulation.L312,一种通过选择性调节具有强效抗糖尿病活性的新型过氧化物酶体增殖物激活受体γ(PPARγ)配体。
Biochim Biophys Acta. 2015 Jan;1850(1):62-72. doi: 10.1016/j.bbagen.2014.09.027. Epub 2014 Oct 12.
4
Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.体内脂肪细胞中过氧化物酶体增殖物激活受体γ(PPARγ)活性增加对肥胖、胰岛素敏感性及罗格列酮治疗效果的影响。
Endocr J. 2008 Aug;55(4):767-76. doi: 10.1507/endocrj.k08e-018. Epub 2008 May 28.
5
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.抗糖尿病药物通过 Cdk5 抑制肥胖相关的 PPARγ磷酸化。
Nature. 2010 Jul 22;466(7305):451-6. doi: 10.1038/nature09291.
6
PPARγ-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice.PPARγ-K107 SUMOylation 调节小鼠的胰岛素敏感性但不影响其肥胖程度。
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):12102-12111. doi: 10.1073/pnas.1814522115. Epub 2018 Nov 12.
7
Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.过氧化物酶体增殖物激活受体 γ 及其在脂肪细胞稳态和噻唑烷二酮介导的胰岛素敏感性中的作用。
Mol Cell Biol. 2018 Apr 30;38(10). doi: 10.1128/MCB.00677-17. Print 2018 May 15.
8
FAK signalling controls insulin sensitivity through regulation of adipocyte survival.FAK 信号通路通过调节脂肪细胞存活控制胰岛素敏感性。
Nat Commun. 2017 Feb 6;8:14360. doi: 10.1038/ncomms14360.
9
PPAR gamma gene--a review.过氧化物酶体增殖物激活受体γ基因——综述
Diabetes Metab Syndr. 2015 Jan-Mar;9(1):46-50. doi: 10.1016/j.dsx.2014.09.015. Epub 2014 Oct 13.
10
Lack of CUL4B in Adipocytes Promotes PPARγ-Mediated Adipose Tissue Expansion and Insulin Sensitivity.脂肪细胞中CUL4B的缺失促进PPARγ介导的脂肪组织扩张和胰岛素敏感性。
Diabetes. 2017 Feb;66(2):300-313. doi: 10.2337/db16-0743. Epub 2016 Nov 29.

引用本文的文献

1
The effects of alpha lipoic acid (ALA) supplementation on blood pressure in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.补充α-硫辛酸(ALA)对成年人血压的影响:一项采用GRADE评估的随机对照试验系统评价和剂量反应荟萃分析。
Front Cardiovasc Med. 2023 Oct 24;10:1272837. doi: 10.3389/fcvm.2023.1272837. eCollection 2023.
2
Sexual dimorphic gene expression profile of perirenal adipose tissue in ovine fetuses with growth restriction.生长受限绵羊胎儿肾周脂肪组织的性二态性基因表达谱
Front Physiol. 2023 Aug 4;14:1179288. doi: 10.3389/fphys.2023.1179288. eCollection 2023.
3
Enriched functional milk fat ameliorates glucose intolerance and triacylglycerol accumulation in skeletal muscle of rats fed high-fat diets.富含功能性乳脂肪可改善高脂饮食喂养大鼠骨骼肌中的葡萄糖不耐受和甘油三酯积累。
Eur J Nutr. 2023 Apr;62(3):1535-1550. doi: 10.1007/s00394-023-03098-9. Epub 2023 Jan 28.
4
The adipocyte-enriched secretory protein tetranectin exacerbates type 2 diabetes by inhibiting insulin secretion from β cells.富含脂肪细胞的分泌蛋白四旋蛋白通过抑制β细胞胰岛素分泌而加重 2 型糖尿病。
Sci Adv. 2022 Sep 23;8(38):eabq1799. doi: 10.1126/sciadv.abq1799. Epub 2022 Sep 21.
5
The effect of the PLIN1 gene on the metabolism and mitochondria of porcine skeletal muscle satellite cells.PLIN1基因对猪骨骼肌卫星细胞代谢及线粒体的影响。
Genes Genomics. 2022 Dec;44(12):1555-1563. doi: 10.1007/s13258-022-01252-x. Epub 2022 Apr 19.
6
Common Variation in Regulatory Regions Highlights the Role of PPARγ as a Key Regulator of Endothelin .调控区域的常见变异凸显了PPARγ作为内皮素关键调节因子的作用。
Front Cardiovasc Med. 2022 Feb 25;9:823133. doi: 10.3389/fcvm.2022.823133. eCollection 2022.
7
Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes.在追求单基因糖尿病精准医学的真正方法中,可操作基因的作用。
Genes (Basel). 2022 Jan 9;13(1):117. doi: 10.3390/genes13010117.
8
Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα.介导过氧化物酶体脂肪酸β-氧化的 PPARα 调节机制。
Int J Mol Sci. 2021 Aug 20;22(16):8969. doi: 10.3390/ijms22168969.
9
Comparative Transcriptome Analysis of Key Genes and Pathways Activated in Response to Fat Deposition in Two Sheep Breeds With Distinct Tail Phenotype.两种具有不同尾型表型的绵羊品种中响应脂肪沉积而激活的关键基因和通路的比较转录组分析
Front Genet. 2021 Apr 8;12:639030. doi: 10.3389/fgene.2021.639030. eCollection 2021.
10
PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer.过氧化物酶体增殖物激活受体-γ(PPAR-γ)诱导 AKT3 表达增加,促进了线粒体生物发生,从而驱动前列腺癌的发生。
Oncogene. 2021 Apr;40(13):2355-2366. doi: 10.1038/s41388-021-01707-7. Epub 2021 Mar 2.

本文引用的文献

1
Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.成纤维细胞生长因子 21 调节过氧化物酶体增殖物激活受体 γ 的活性和噻唑烷二酮类药物的抗糖尿病作用。
Cell. 2012 Feb 3;148(3):556-67. doi: 10.1016/j.cell.2011.11.062.
2
O-GlcNAc modification of PPARγ reduces its transcriptional activity.O-GlcNAc 修饰降低了 PPARγ 的转录活性。
Biochem Biophys Res Commun. 2012 Jan 27;417(4):1158-63. doi: 10.1016/j.bbrc.2011.12.086. Epub 2011 Dec 27.
3
Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity.脂肪细胞 NCoR 敲除可减少 PPARγ 磷酸化,增强 PPARγ 活性和胰岛素敏感性。
Cell. 2011 Nov 11;147(4):815-26. doi: 10.1016/j.cell.2011.09.050.
4
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.一种非激动剂 PPARγ 配体通过阻断 Cdk5 介导的磷酸化发挥抗糖尿病作用。
Nature. 2011 Sep 4;477(7365):477-81. doi: 10.1038/nature10383.
5
Cyclin-dependent kinases in brain development and disease.细胞周期蛋白依赖性激酶在脑发育和疾病中的作用。
Annu Rev Cell Dev Biol. 2011;27:465-91. doi: 10.1146/annurev-cellbio-092910-154023. Epub 2011 Jul 5.
6
Acetylation and nuclear receptor action.乙酰化和核受体作用。
J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):91-100. doi: 10.1016/j.jsbmb.2010.12.003. Epub 2010 Dec 15.
7
Comparative epigenomic analysis of murine and human adipogenesis.小鼠和人类脂肪生成的比较表观基因组分析。
Cell. 2010 Oct 1;143(1):156-69. doi: 10.1016/j.cell.2010.09.006.
8
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.抗糖尿病药物通过 Cdk5 抑制肥胖相关的 PPARγ磷酸化。
Nature. 2010 Jul 22;466(7305):451-6. doi: 10.1038/nature09291.
9
Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages.脂肪细胞和巨噬细胞中过氧化物酶体增殖物激活受体 γ 功能的细胞特异性决定因素。
Mol Cell Biol. 2010 May;30(9):2078-89. doi: 10.1128/MCB.01651-09. Epub 2010 Feb 22.
10
Casein-kinase-II-dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol.酪蛋白激酶 II 依赖性磷酸化 PPARγ 引发 CRM1 介导的 PPARγ 从细胞核到细胞质的易位。
J Cell Sci. 2010 Jan 15;123(Pt 2):192-201. doi: 10.1242/jcs.055475. Epub 2009 Dec 21.